A Prospective Randomized-controlled Study on Effectiveness of Extended-release Liposomal Bupivacaine in Postoperative Pain Control
Phase of Trial: Phase IV
Latest Information Update: 23 Oct 2018
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms PAIN
- 22 Nov 2017 Status changed from recruiting to completed.
- 18 Jun 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2017 to 1 Dec 2018.
- 18 Jun 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.